Home > Boards > US Listed > Biotechs >

RedHill Biopharma Ltd. (RDHL)

RDHL RSS Feed
Add RDHL Price Alert      Hide Sticky   Hide Intro
Moderator: mick, midastouch017, Insightfulpenguin, Chasing
Search This Board: 
Last Post: 9/29/2020 6:43:07 AM - Followers: 78 - Board type: Free - Posts Today: 1

O/S: 35.27M ~~~ FLOAT: 33.4M ~~~MKT CAP: 296M
Float Ownership Estimates
15.37% Insider holding : 5,225,800
20.91% Institutions : 7,109,400
.36% Mutual Funds : 122,900
59.56% Publicly Available : 20,250,400



 


COVID PIPELINE
Opaganib blocks SARS-Cov-2 virus replication



Opaganib
 
The development of opaganib has been supported by grants and contracts from U.S. federal and state government agencies awarded to Apogee Biotechnology Corp, totaling over $14 million.[1]

NCI
BARDA 
U.S. Department of Defense
FDA Office of Orphan Products Development


 


RECENT FUNDING
$300,000 grant from the State of Pennsylvania’s COVID-19 Vaccines, Treatments and Therapies (CV-VTT) Program [2]
 
 

RECENT DRUG NEWS
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARSCoV2
RedHill Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico
RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19


UPCOMING CATALYSTS 

The Sixth Annual PharmaVOICE 100 Celebration
Bioforum Panel Presentation: Thursday, September 10, 2020
Topic: Developing Clinical Trial Outsourcing Strategies that Scale as Biotechs Do
Time: 12:10 a.m. EDT 
Speaker: Guy Goldberg, Chief Business Officer

The Wall Street Investor Forum
Presentation: Thursday, September 10, 2020
Time: 11:40 a.m. EDT
Speaker: Dror Ben-Asher, Chief Executive Officer

H.C. Wainwright 22nd Annual Healthcare Conference (Sept. 14-16)
Presentation and Q&A: Wednesday, September 16, 2020
Time: 10:00 a.m. EDT
Speaker: Guy Goldberg, Chief Business Officer

Morgan Stanley Virtual 18th Annual Global Healthcare Conference (Sept. 14-18)
Fireside chat and Q&A: Thursday, September 17, 2020
Time: 8:45 a.m. EDT
Speaker: Dror Ben-Asher, Chief Executive Officer

Healthtech Leaders Virtual Partnering & Investment Conference (Sept. 15-18)
Presentation: On-demand
Speaker: Guy Goldberg, Chief Business Officer

Sachs 20th Annual Biotech in Europe Forum (Sept. 21-24)
Presentation: On-demand
Speaker: Guy Goldberg, Chief Business Officer

Panel: Virtual Therapeutic Strategies to Prevent & Treat COVID-19
Date: Monday, September 21, 2020
Time: 10:00 a.m. EDT/4:00 p.m. CET
Speaker: Gilead Raday, Chief Operating Officer



 
 

RedHill Biopharma Ltd.

21 Ha'arba'a Street
Tel Aviv 6473921
Israel
972 3 541 3131
http://www.redhillbio.com

[1] https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=1358&PID=0&IID=1899
[2] https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=2432&PID=0&IID=17299






$RDHL https://www.otcmarkets.com/stock/RDHL/disclosure

https://www.otcmarkets.com/stock/RDHL/news

https://www.otcmarkets.com/stock/RDHL/security

https://www.otcmarkets.com/stock/RDHL/profile

https://www.otcmarkets.com/stock/RDHL/quote

https://www.otcmarkets.com/stock/RDHL/overview





 *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.















 
RDHL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RDHL News: Report of Foreign Issuer (6-k) 09/22/2020 07:15:13 AM
RDHL News: Report of Foreign Issuer (6-k) 09/09/2020 07:00:51 AM
RDHL News: Report of Foreign Issuer (6-k) 09/03/2020 07:07:34 AM
RDHL News: Report of Foreign Issuer (6-k) 08/27/2020 07:01:03 AM
RDHL News: Report of Foreign Issuer (6-k) 08/13/2020 06:10:57 AM
PostSubject
#2300  Sticky Note RedHill Biopharma Ltd. (RDHL) estimates and forecasts midastouch017 09/10/20 01:27:49 AM
#2251  Sticky Note RedHill's opaganib shows encouraging action against SARS-CoV-2 in midastouch017 09/08/20 11:49:42 AM
#2420   I missed it- searching now. JJPow 09/29/20 06:43:07 AM
#2419   did anyone catch the clip of Fauci talking GMoney74 09/28/20 10:01:01 AM
#2418   Redhill Boipharma Lt (RDHL) mick 09/25/20 07:50:33 PM
#2417   ........................ JJPow 09/25/20 09:34:08 AM
#2416   Hope you find the bottom of the cup. JJPow 09/25/20 07:59:04 AM
#2415   JJ - beautiful day for golf here in CA XWAVXALMIMAN 09/24/20 09:50:50 PM
#2414   RedHill Biopharma Corporate Presentation (Sept 22 2020) stockguard 09/24/20 06:01:37 PM
#2413   Nothing to post about as we wait on stockguard 09/24/20 05:54:51 PM
#2412   I hope so. The market is heading south Shady outlook 09/24/20 10:35:48 AM
#2411   Any news on the horizon? JJPow 09/24/20 09:03:56 AM
#2410   Veeva Systems Enlisted To Help In Study Of midastouch017 09/23/20 11:47:35 AM
#2409   I’m still here too Shady outlook 09/23/20 11:09:13 AM
#2408   Long and strong! GMoney74 09/23/20 11:07:07 AM
#2407   Are you guys even alive out here??? what JJPow 09/23/20 10:42:41 AM
#2406   Methinks the 52W/H of $11.35 midastouch017 09/23/20 08:54:39 AM
#2405   All systems are go... looks like a great JJPow 09/23/20 08:43:22 AM
#2404   Veeva and Bioforum Partner with RedHill Biopharma to midastouch017 09/23/20 08:03:10 AM
#2403   Veeva partners with RedHill Bio to advance Opaganib midastouch017 09/23/20 07:58:06 AM
#2402   this stock is so undervalued. 350mm market cap GMoney74 09/22/20 03:18:30 PM
#2401   RedHill Biopharma on go with Phase 2/3 COVID-19 midastouch017 09/22/20 01:24:32 PM
#2400   From today's PR: midastouch017 09/22/20 11:58:04 AM
#2399   Brazil Approves RedHill Biopharma’s Phase 2/3 COVID-19 Study midastouch017 09/22/20 11:57:02 AM
#2398   great news this am. saw they posted "Multiple GMoney74 09/22/20 10:05:26 AM
#2397   BCYC-Presentations ESMO SEPTEMBER 17, 2020 stockguard 09/20/20 07:30:57 PM
#2396   DorseyE stockguard 09/20/20 06:59:27 PM
#2395   Are you sure about the float? DorseyE 09/19/20 07:47:19 PM
#2394   Could not resist buying more on the dip stockguard 09/19/20 03:05:17 PM
#2393   Thanks for the link. Very interesting and great XWAVXALMIMAN 09/17/20 10:57:26 AM
#2392   Is there a link for this meeting? midastouch017 09/17/20 02:19:18 AM
#2391   Is there a link for this meeting? XWAVXALMIMAN 09/16/20 05:39:34 PM
#2390   Perhaps so, but since i am not into midastouch017 09/16/20 11:44:44 AM
#2389   So traders buying in before Morgan Stanley meeting DorseyE 09/16/20 10:14:55 AM
#2388   Yep i was referring to the july 2018 high GMoney74 09/16/20 09:52:07 AM
#2387   we are gonna test the 11.49 high midastouch017 09/16/20 09:47:29 AM
#2386   Unfortunately for my investments but I feel the DorseyE 09/16/20 04:53:10 AM
#2385   GONNA BE ONE OF THE TOP 10 GAINERS FRAKSTER 09/15/20 10:04:06 PM
#2384   #1 holding of ARK Israel fund XWAVXALMIMAN 09/15/20 06:34:50 PM
#2383   monster day! so glad i added on the GMoney74 09/15/20 03:37:53 PM
#2382   Sorry for your loss Amatuer. midastouch017 09/15/20 02:16:04 PM
#2381   IMO - investing money in certain companies in Amatuer17 09/15/20 01:59:58 PM
#2380   I see your point, for me it is midastouch017 09/15/20 01:45:50 PM
#2379   I am on border and move between black Amatuer17 09/15/20 01:39:44 PM
#2378   If i remember correctly you are midastouch017 09/15/20 01:17:05 PM
#2377   For some reason - this stock cannot retain Amatuer17 09/15/20 12:18:52 PM
#2376   We are here, in the FETAL position waiting patiently.... DorseyE 09/15/20 12:09:12 PM
#2375   Ello no news... but great tech bounce GMoney74 09/15/20 10:47:59 AM
#2374   People buying on dip XWAVXALMIMAN 09/15/20 10:17:24 AM
#2373   Hello? Anybody home? JJPow 09/15/20 09:48:21 AM
#2372   Nice open. Is there news? JJPow 09/15/20 09:44:03 AM
#2371   anything over 2 mil would be very nice. DailyTrades 09/14/20 04:44:05 PM
PostSubject
Consent Preferences